Validation and utility of HepG2 xenograft model for hepatocellular carcinoma

Eur J Nucl Med Mol Imaging. 2023 Feb;50(3):639-641. doi: 10.1007/s00259-022-06043-w. Epub 2022 Nov 22.

Yangmeihui Song^{1

2}, Qiaomiao Lu^{1

2}, Dawei Jiang^{1

2

3}, Xiaoli Lan^{4

5

6}

¹ Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, Hubei, China.
² Hubei Key Laboratory of Molecular Imaging, Wuhan, 430022, Hubei, China.
³ Key Laboratory of Biological Targeted Therapy of the Ministry of Education, Wuhan, 430022, Hubei, China.
⁴ Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, Hubei, China. xiaoli_lan@hust.edu.cn.
⁵ Hubei Key Laboratory of Molecular Imaging, Wuhan, 430022, Hubei, China. xiaoli_lan@hust.edu.cn.
⁶ Key Laboratory of Biological Targeted Therapy of the Ministry of Education, Wuhan, 430022, Hubei, China. xiaoli_lan@hust.edu.cn.

No abstract available

Publication types